Peptide compound
HGH Fragment 176-191
Modified GH C-terminal fragment investigated for lipolysis research.
— Tracked fulfillment · COA included · Discreet packaging
COA · IncludedPurity
>99%
Form
Lyophilized
Storage
-20°C
Grade
Research
— Overview
HGH Fragment 176-191 at a glance.
HGH Fragment 176-191 is a synthetic peptide corresponding to amino acids 176–191 of the human growth hormone polypeptide. Research interest centers on lipolytic effects without the broader proliferative actions associated with full-length GH.
— From the clinic
Peptides aren't a substitute for the protocol around them. We design dose, cycle, and stack against your labs and your goals — not a generic vial in a drawer.
Pairs well with
Common stack partners.
peptide solutions
CJC-1295 with DAC
GHRH analog with DAC tag for extended GH-release research.
peptide solutions
Ipamorelin
Selective growth-hormone secretagogue for pulsatile GH-release research.
peptide solutions
GLP-1
GLP-1 receptor agonist (semaglutide-class) for satiety research.
— Want supervision?
Pair HGH Fragment 176-191 with a
physician-designed protocol.
Stria Performance and Complete tiers include physician-prescribed peptides with comprehensive labs and quarterly follow-up. Take the assessment to see which fits.